Earlier this month, International Space Station astronaut Jasmin Moghbeli captured absolutely stunning pictures of a flag-like green aurora stretching from the southern regions of the Earth far up into space.
“Every time I look out the window, I’m in awe.”
Researchers found microplastics in layers of sediment that date back as early as the first half of the 18th Century.
An AI-trained surgical robot that can make a few stitches on its own is a small step toward systems that can aid surgeons with such repetitive tasks.
The robot was able to sew six stitches all on its own—and has lessons for robotics as a whole.
I use Blackmagic Design’s Davinci Resolve for editing 4K and above video. If you have edited video you experience glitches that can be solved with answers. OpenAI has this chatbot that is a Davinci Resolve expert, that can answer your questions when problems arise. This is pretty cool indeed.
Friendly DaVinci Resolve expert, guiding users with easy-to-understand advice and forum insights.
Interested in learning more about the dynamic field of bioinformatics? Explore our guide to how bioinformatics is revolutionising personalised healthcare.
A team of Rutgers undergraduates has shown that an experimental drug known as Yoda1 may help drain cranial waste plus neurotoxins that cause Alzheimer’s disease and other forms of dementia.
Rutgers study led by undergrads and gap-year students breaks ground in the field of neuroscience and suggests experimental medication could treat dementia.
🤖 🧠 💡
A study in PNAS evaluates AI chatbots against human benchmarks, revealing that AI exhibits human-like behaviors and personality traits, with ChatGPT-4 closely mirroring human responses in strategic decision-making and personality assessments.
Lydia Hu reports on the latest artificial intelligence news that major companies are using a new software to monitor employee conversations.
The more we learn about Earth’s past, the wilder it gets.
Known as the Radcliffe Wave, astronomers have discovered that this chain of stars, gas, and dust is propagating like a wave, too.
“This trial has changed the lives of people with mesothelioma, allowing us to live longer,” said one of the patients who benefited from the drug. The 80-year-old, who wished to remain anonymous, won compensation from his former employer after being exposed to asbestos in a factory in the 1970s.
He was given four months to live, but thanks to the trial is still alive five years later. “I have five grandchildren and two great-grandchildren now – I wouldn’t want to miss all that,” he said.
The breakthrough is significant, experts say, because mesothelioma has one of the lowest survival rates of any cancer. The new drug, ADI-PEG20 (pegargiminase), is the first of its kind to be successfully combined with chemotherapy in 20 years.
